News

BIO5 members Russell Witte, Julie Ledford, Christopher Hulme, Steven Goldman, Elise Erickson, and Zong-Ming Li received $100K Flinn Foundation Seed Grants to advance research in areas like pain management, cancer, and Parkinson's disease.

BIO5 member Rachna Shroff, led a clinical trial that found that triplet chemotherapy did not improve survival for patients with advanced biliary tract cancer, highlighting the need for better treatment options.

BIO5 member Elise Erickson leads maternal health research by focusing on oxytocin response, biological age, and AI-based pregnancy predictions to improve global healthcare outcomes.

BIO5 member Michael D.L. Johnson is researching how copper can combat antibiotic-resistant bacteria, particularly Streptococcus pneumoniae, with a $1.9 million NIH grant. His work aims to understand copper's toxicity to bacteria and develop new treatments.

BIO5 member Melissa Herbst-Kralovetz led a study showing higher HPV and dysbiosis rates in Native American women, increasing cervical cancer risk, with a focus on prevention through microbiome modulation.

Growing up in Vail, Zachary Boydell pushed himself out of his comfort zone to apply for the KEYS Research Internship and discover a passion for neuroscience that led him to attend the University of Arizona.

As 2024 winds to a close, BIO5 Institute director Jennifer Barton recalls some top moments of the year and shares what excites her for the year ahead.

Over 40 Arizona bioscience industry representatives and University of Arizona researchers mingled at the fifth annual Faculty Industry Networking event in mid-November.

BIO5 member Joanna Masel, senior author of a PNAS study, led research challenging the understanding of genetic code evolution. The team discovered earlier genetic codes evolved differently, revising key evolutionary assumptions.